2828 J . Org. Chem., Vol. 63, No. 9, 1998
Gyenes et al.
Gen er a l Meth od for th e Rela tive Rea ctivity. A pair of
aldehydes (the parent and substituted, 1.95 mmol each) in 3
mL of dry ether were added to a solution of LiHMDS (4.3
mmol) in 5 mL of dry ethyl ether, and the solution was stirred
for 30 min. The Barbier-type reaction was performed in the
same manner as before. After aqueous workup of the reaction,
the ratio of the two amines was determined by GC from the
crude product.
cm-1; 1H NMR (CDCl3) δ 7.14 (m, 5H), 3.07 (m, 1H), 2.62 (dd,
J ) 5.6, 13.4 Hz, 1H), 2.43 (dd, J ) 8.2, 13.2 Hz, 1H), 1.75 (b,
2H), 1.03 (d, J ) 6.2 Hz, 3H); 13C NMR (CDCl3) δ 139.4, 129.0,
128.1, 125.9, 48.3, 46.4, 23.3.
1-P h en ylbu ta n -2-a m in e28 (9b): IR (neat) 3352, 3264 cm-1
;
1H NMR (CDCl3) δ 7.22 (m, 5H), 4.30 (br, 2H), 3.05 (m, 1H),
2.83 (dd, J ) 13.4, 6.2 Hz, 1H), 2.73 (dd, J ) 13.2, 7.8 Hz,
1H), 1.53 (m, 2H), 0.98 (t, J ) 7.3 Hz, 3H); 13C NMR (CDCl3)
δ 138.0, 129.1, 128.3, 126.2, 54.2, 41.6, 27.8, 10.1.
1-(4-(N′,N′-Dim et h yla m in o)p h en yl)-2-p h en ylet h a n -1-
1
a m in e (5a ): IR (neat) 3363, 3300 cm-1; H NMR (CDCl3) δ
3-Meth yl-1-p h en ylbu ta n -2-a m in e29 (9c): IR (neat) 3375,
3307 cm-1; 1H NMR (CDCl3) δ 7.18 (m, 5H), 2.78 (dd, J ) 10.0,
4.1 Hz, 1H), 2.41 (dd, J ) 14.1, 10.0 Hz, 1H), 2.28 (br, 2H),
1.64 (m, 1H), 0.94 (dd, J ) 6.2, 6.2 Hz, 6H); 13C NMR (CDCl3)
δ 139.7, 129.1, 128.3, 126.0, 58.1, 40.6, 32.4, 19.2, 17.3.
3′,3-Dim eth yl-1-p h en ylbu ta n -2-a m in e (9d ): IR (neat)
3385, 3325 cm-1; 1H NMR (CDCl3) δ 7.25 (m, 5H), 2.98 (dd, J
) 13.2, 2.1 Hz, 1H), 2.69 (dd, J ) 11.0, 2.3 Hz, 1H), 2.22 (dd,
J ) 13.2, 11.0 Hz, 1H), 1.21 (br, 2H), 1.01 (s, 9H); 13C NMR
(CDCl3) δ 140.7, 128.9, 128.2, 125.8, 61.8, 38.4, 34.0, 26.1. Anal.
Calcd for C12H19N: C, 81.30; H, 10.80. Found: C, 81.40; H,
11.00.
7.4-6.7 (br, 9H), 4.15 (dd, J ) 8.7, 4.8 Hz, 1H), 3.05 (dd, J )
13.2, 5.1 Hz, 1H), 2.98 (s, 6H), 2.87 (dd, J ) 13.1, 8.9 Hz, 1H),
1.83 (br, 2H); 13C NMR (CDCl3) δ 149.6, 139.3, 133.2, 129.1,
128.1, 126.9, 126.0, 112.4, 56.7, 46.2, 40.5. Anal. Calcd for
C
16H20N: C, 79.95; H, 8.38. Found: C, 79.88; H, 8.34.
1-(4-Meth oxyp h en yl)-2-p h en yleth a n -1-a m in e25 (5b): IR
(neat) 3373, 3316 cm-1; H NMR (CDCl3) δ 7.3-7.1 (br, 9H),
1
4.16 (dd, J ) 7.9, 6.0 Hz, 1H), 3.78 (s, 3H), 3.01 (dd, J ) 13.3,
5.7 Hz, 1H), 2.90 (dd, J ) 13.2, 8.2 Hz, 1H), 2.67 (br, 2H); 13
C
NMR (CDCl3) δ 158.5, 138.6, 136.4, 129.2, 128.2, 127.5, 126.2,
113.6, 56.9, 55.1, 45.9. Anal. Calcd for C15H17N: C, 79.26; H,
7.54. Found: C, 79.09; H, 7.50.
3-Eth yl-1-p h en ylp en ta n -2-a m in e (9e): IR (neat) 3374,
3310 cm-1; 1H NMR (CDCl3) δ 7.22 (m, 5H), 3.19 (dd, J ) 7.9,
4.3 Hz, 1H), 2.85 (dd, J ) 13.5, 5.0 Hz, 1H), 2.59 (dd, J ) 12.8,
9.3 Hz, 1H), 1.49 (m, 2H), 1.36 (m, 2H), 1.24 (br, 2H), 0.95 (t,
J ) 7.2 Hz, 3H), 0.90 (t, J ) 7.2 Hz, 3H); 13C NMR (CDCl3) δ
139.4, 129.1, 128.4, 126.1, 54.2, 45.4, 39.9, 22.3, 21.5, 12.0, 11.9.
Anal. Calcd for C13H21N: C, 81.61; H, 11.06. Found: C, 81.46;
H, 10.93.
1-(4-Meth ylp h en yl)-2-p h en yleth a n -1-a m in e26 (5c): IR
1
(neat) 3356, 3287 cm-1; H NMR (CDCl3) δ 7.2-7.0 (br, 9H),
4.08 (dd, J ) 7.0, 7.0 Hz, 1H), 3.62 (br, 2H), 2.94 (dd, J ) 13.2,
6.2 Hz, 1H), 2.87 (dd, J ) 13.3, 7.9 Hz, 1H), 2.21 (s, 3H); 13C
NMR (CDCl3) δ 140.0, 138.2, 136.9, 129.2, 129.0, 128.2, 126.5,
126.3, 57.2, 45.0, 21.0.
2-P h en yleth a n -1-a m in e25 (5d ): IR (neat) 3375, 3300 cm-1
;
1H NMR (CDCl3) δ 7.28 (m, 10H), 4.22 (dd, J ) 8.8, 4.9 Hz,
1H), 3.03 (dd, J ) 13.3, 4.9 Hz, 2H), 2.85 (dd, J ) 13.3, 8.9
Hz, 1H), 1.66 (b, 2H); 13C NMR (CDCl3) δ 145.5, 138.9, 129.2,
128.3, 127.0, 126.35, 126.31, 57.4, 46.0.
2-Cycloh exyl-1-p h en ylet h a n -2-a m in e (9f): IR (neat)
1
3374, 3305 cm-1; H NMR (CDCl3) δ 7.35-7.15 (br, 5H), 2.87
(dd, J ) 13, 3.9 Hz, 1H), 2.81 (dd, J ) 4.0, 3.4 Hz, 2H), 2.43
(dd, J ) 12.0, 9.6 Hz, 1H), 1.91 (br, 2H), 1.9-1.5 (br, 5H), 1.4-
0.9 (br, 6H); 13C NMR (CDCl3) δ 140.0, 129.2, 128.4, 126.1,
57.6, 43.1, 40.9, 29.7, 28.1, 26.5, 26.4, 26.3. Anal. Calcd for
1-(4-F lu or op h en yl)-2-p h en ylet h a n -1-a m in e (5e): IR
(neat) 3373, 3298 cm-1; 1H NMR (CDCl3) δ 7.15 (m, 9H), 4.21
(br, 1H), 2.98 (dd, J ) 13.0, 4.9 Hz, 1H), 2.84 (dd, J ) 13.2,
C
14H21N: C, 82.70; H, 10.41. Found: C, 82.49; H, 10.21.
8.5 Hz, 1H), 1.91 (b, 2H); 13C NMR (CDCl3) δ 161.8 (d, J 1
)
(l,u )-3-Meth yl-1-p h en ylh exa n -2-a m in e (9g): IR (neat)
C-F
245 Hz), 140.8, 138.5 (d, J 4
) 2.7 Hz), 129.2, 128.3, 127.9
3375, 3307 cm-1; 1H NMR (CDCl3) δ 7.2 (m, 5H), 3.0-2.7 (br,
2H), 2.41 (m, 1H), 1.6-1.3 (br, 3H), 1.3-1.1 (br, 4H), 0.93 (m,
6H); 13C NMR (CDCl3) δ 1140.1, 140.0, 129.0, 128.9, 128.2,
125.8, 57.2, 56.4, 41.6, 40.2, 37.9, 37.2, 35.9, 34.5, 20.4, 20.3,
15.4, 14.2, 14.1, 13.7. Anal. Calcd for C13H21N1: C, 81.61; H,
11.06. Found: C, 81.39; H, 11.03.
C-F
(d, J 3
) 8 Hz), 126.3, 115.0 (d, J 2
) 21.6 Hz), 56.8, 46.3;
C-F
C-F
19F NMR (CDCl3) δ -63.07. Anal. Calcd for C14H14N: C,
78.11; H, 6.56. Found: C, 78.35; H, 6.72.
1-(4-Ch lor op h en yl)-2-p h en yleth a n -1-a m in e26 (5f): IR
1
(neat) 3370, 3297 cm-1; H NMR (CDCl3) δ 7.4-7.1 (br, 9H),
4.19 (m, 1H), 3.03 (dd, J ) 13.5, 5.0 Hz, 1H), 2.82 (dd, J )
13.2, 8.5 Hz, 1H), 1.58 (br, 2H); 13C NMR (CDCl3) δ 143.9,
138.4, 132.4, 129.2, 128.3, 127.7, 126,3, 56.8, 46.3.
Ack n ow led gm en t. Financial support of this work
by the National Science Foundation Grant CHE-
8901986 and National Institute of Health Grant AI33690
is gratefully acknowledged. The authors are also grate-
ful for the helpful comments and suggestions of Prof.
Paul Toscano and Prof. Barry Carpenter.
1-(4-(r′,r′,r′-Tr iflu or om et h yl)p h en yl)-2-p h en ylet h a n -
1-a m in e (5g): IR (neat) 3364, 3283 cm-1; 1H NMR (CDCl3) δ
7.53 (m, 4H), 7.30-7.15 (br, 5H), 4.28 (dd, J ) 5.2, 8.4 Hz,
1H), 3.00 (dd, J ) 5.0, 13.5 Hz, 1H), 2.85 (dd, J ) 8.7, 13.2
Hz, 1H), 1.85 (br, 2H); 13C NMR (CDCl3) δ 149.4, 138.3, 161.8
(q, J 2
) 270 Hz), 129.3, 128.5, 126.8, 126.6, 125.3 (q J 1
C-F
C-F
J O971061R
) 270 Hz), 57.2, 46.3; 19F NMR (CDCl3) δ -62.9.
1-P h en ylp r op a n -2-a m in e27 (9a ): IR (neat) 3355, 3296
(27) Mori, A.; Ishiyama, I.; Akita, H.; Suzuki, K.; Mitsuoka, T.; Oishi,
T. Chem. Pharm. Bull. 1990, 38, 3449-3451.
(28) (a) Hornback, J . M.; Murugaverl, B. Tetrahedron Lett. 1989,
30, 5853-5856. (b) Grunewald, G. L.; Monn, J . A.; Rafferty, M. F.;
Borchardt, R. T.; Krass, P. J . Med. Chem. 1982, 25, 1248.
(29) Son, Y.; Park, C.; Koh, J . S.; Choy, N.; Lee, C. S.; Choi, H.; Kim
S. C.; Yoon H. Tetrahedron Lett. 1994, 35, 3745.
(25) Gee, K. R.; Barmettler, P.; Rhodes, M. R.; McBurney, R. N.;
Reddy, N. L.; Hu, L.-Y.; Cotter, R. E.; Hamilton, P. N.; Weber, E.;
Keana, J . F. W. J . Med. Chem. 1993, 36, 1938-1946.
(26) Nagase, T.; Suzukamo, G.; Suzuki, Y. Ger. Offen. 2,442,845,
1975; Chem. Abstr. 1975, 83, 78820a.